{"id":"https://openalex.org/W1985287360","doi":"https://doi.org/10.1080/10438590802547225","title":"Incentives for clinical trials","display_name":"Incentives for clinical trials","publication_year":2009,"publication_date":"2009-07-01","ids":{"openalex":"https://openalex.org/W1985287360","doi":"https://doi.org/10.1080/10438590802547225","mag":"1985287360"},"language":"en","primary_location":{"id":"doi:10.1080/10438590802547225","doi":"https://doi.org/10.1080/10438590802547225","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10438590802547225","pdf_url":null,"source":{"id":"https://openalex.org/S192056284","display_name":"Economics of Innovation and New Technology","issn_l":"1043-8599","issn":["1043-8599","1476-8364"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-b","anvur-class-a","anvur-scientific","cwts-core","fnege-3","jufo-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Economics of Innovation and New Technology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060712201","display_name":"Erik Gr\u00f6nqvist","orcid":"https://orcid.org/0000-0002-6209-4407","observed_orcids":["https://orcid.org/0000-0002-6209-4407"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Erik Gr\u00f6nqvist","raw_affiliation_strings":["Institute for Labour Market Policy Evaluation, P.O. Box 513, SE-751 20, Uppsala, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Labour Market Policy Evaluation, P.O. Box 513, SE-751 20, Uppsala, Sweden","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5102140129","display_name":"Douglas Lundin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405273355","display_name":"Swedish Competition Authority","ror":"https://ror.org/05pxb3s26","country_code":"SE","type":"government","lineage":["https://openalex.org/I4405273355"]}],"countries":["SE"],"is_corresponding":false,"raw_author_name":"Douglas Lundin","raw_affiliation_strings":["Swedish Competition Authority, SE-103 85, Stockholm, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Swedish Competition Authority, SE-103 85, Stockholm, Sweden","institution_ids":["https://openalex.org/I4405273355"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5060712201"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.27384975,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"18","issue":"5","first_page":"513","last_page":"531"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11043","display_name":"Merger and Competition Analysis","score":0.004900000058114529,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11161","display_name":"Consumer Market Behavior and Pricing","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1406","display_name":"Marketing"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmaceutical-industry","display_name":"pharmaceutical industry","score":0.7749999761581421},{"id":"https://openalex.org/keywords/vertical-product-differentiation","display_name":"vertical differentiation","score":0.8029999732971191},{"id":"https://openalex.org/keywords/quality-uncertainty","display_name":"quality uncertainty","score":0.8420000076293945},{"id":"https://openalex.org/keywords/product-differentiation","display_name":"product differentiation","score":0.8410000205039978},{"id":"https://openalex.org/keywords/drug-pricing","display_name":"drug pricing","score":0.7409999966621399},{"id":"https://openalex.org/keywords/price-caps","display_name":"price caps","score":0.6650000214576721},{"id":"https://openalex.org/keywords/consumer-welfare","display_name":"consumer welfare","score":0.4180000126361847}],"concepts":[{"id":"https://openalex.org/C29122968","wikidata":"https://www.wikidata.org/wiki/Q1414816","display_name":"Incentive","level":2,"score":0.7658480405807495},{"id":"https://openalex.org/C2779530757","wikidata":"https://www.wikidata.org/wiki/Q1207505","display_name":"Quality (philosophy)","level":2,"score":0.6322506666183472},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6142378449440002},{"id":"https://openalex.org/C2776299755","wikidata":"https://www.wikidata.org/wiki/Q432449","display_name":"Carry (investment)","level":2,"score":0.5301573872566223},{"id":"https://openalex.org/C2777673361","wikidata":"https://www.wikidata.org/wiki/Q5281228","display_name":"Disadvantage","level":2,"score":0.5278090238571167},{"id":"https://openalex.org/C90673727","wikidata":"https://www.wikidata.org/wiki/Q901718","display_name":"Product (mathematics)","level":2,"score":0.5215551853179932},{"id":"https://openalex.org/C2992672634","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Drug trial","level":3,"score":0.4826520085334778},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.473176509141922},{"id":"https://openalex.org/C33556415","wikidata":"https://www.wikidata.org/wiki/Q1200129","display_name":"Product differentiation","level":3,"score":0.4286878705024719},{"id":"https://openalex.org/C162324750","wikidata":"https://www.wikidata.org/wiki/Q8134","display_name":"Economics","level":0,"score":0.421589732170105},{"id":"https://openalex.org/C162118730","wikidata":"https://www.wikidata.org/wiki/Q1128453","display_name":"Actuarial science","level":1,"score":0.41939714550971985},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.41576170921325684},{"id":"https://openalex.org/C2910862244","wikidata":"https://www.wikidata.org/wiki/Q7240896","display_name":"Drug prices","level":2,"score":0.41339021921157837},{"id":"https://openalex.org/C100001284","wikidata":"https://www.wikidata.org/wiki/Q2248246","display_name":"Public economics","level":1,"score":0.3759702444076538},{"id":"https://openalex.org/C175444787","wikidata":"https://www.wikidata.org/wiki/Q39072","display_name":"Microeconomics","level":1,"score":0.21096977591514587},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.17142659425735474},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.1698552370071411},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.16281530261039734},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0703483521938324},{"id":"https://openalex.org/C2524010","wikidata":"https://www.wikidata.org/wiki/Q8087","display_name":"Geometry","level":1,"score":0.0},{"id":"https://openalex.org/C33923547","wikidata":"https://www.wikidata.org/wiki/Q395","display_name":"Mathematics","level":0,"score":0.0},{"id":"https://openalex.org/C16520705","wikidata":"https://www.wikidata.org/wiki/Q601799","display_name":"Cournot competition","level":2,"score":0.0},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.0},{"id":"https://openalex.org/C138885662","wikidata":"https://www.wikidata.org/wiki/Q5891","display_name":"Philosophy","level":0,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C111472728","wikidata":"https://www.wikidata.org/wiki/Q9471","display_name":"Epistemology","level":1,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1080/10438590802547225","doi":"https://doi.org/10.1080/10438590802547225","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10438590802547225","pdf_url":null,"source":{"id":"https://openalex.org/S192056284","display_name":"Economics of Innovation and New Technology","issn_l":"1043-8599","issn":["1043-8599","1476-8364"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["abdc-b","anvur-class-a","anvur-scientific","cwts-core","fnege-3","jufo-1","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Economics of Innovation and New Technology","raw_type":"journal-article"},{"id":"pmh:oai:RePEc:taf:ecinnt:v:18:y:2009:i:5:p:513-531","doi":null,"is_oa":false,"landing_page_url":"http://www.tandfonline.com/doi/abs/10.1080/10438590802547225","pdf_url":null,"source":{"id":"https://openalex.org/S4306401271","display_name":"RePEc: Research Papers in Economics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I77793887","host_organization_name":"Federal Reserve Bank of St. Louis","host_organization_lineage":["https://openalex.org/I77793887"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.46810001134872437,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1489741075","https://openalex.org/W1513281941","https://openalex.org/W1570570810","https://openalex.org/W1580339661","https://openalex.org/W1599449303","https://openalex.org/W1689133548","https://openalex.org/W1972398989","https://openalex.org/W1982069685","https://openalex.org/W1992061418","https://openalex.org/W2042158053","https://openalex.org/W2050670141","https://openalex.org/W2060353900","https://openalex.org/W2063060309","https://openalex.org/W2081031629","https://openalex.org/W2094322305","https://openalex.org/W2105662053","https://openalex.org/W2121175754","https://openalex.org/W2123254140","https://openalex.org/W2126907752","https://openalex.org/W2134891770","https://openalex.org/W2136284733","https://openalex.org/W2143962486","https://openalex.org/W2248615192","https://openalex.org/W2313896093","https://openalex.org/W4249481007","https://openalex.org/W4299678552"],"related_works":["https://openalex.org/W2162851200","https://openalex.org/W2944574521","https://openalex.org/W2014827035","https://openalex.org/W2329376453","https://openalex.org/W2376172771","https://openalex.org/W2037929404","https://openalex.org/W6939628565","https://openalex.org/W4394863717","https://openalex.org/W2191578602","https://openalex.org/W4392287366"],"abstract_inverted_index":{"It":[0,72],"is":[1],"often":[2],"argued":[3],"that":[4,33,40,80],"drug":[5,99,123],"companies":[6,42],"do":[7],"not":[8],"wish":[9],"to":[10,75,89,133],"carry":[11,134],"out":[12,49,135],"post-approval":[13,51,136],"head-to-head":[14],"clinical":[15,52,137],"trials,":[16],"since":[17],"their":[18],"drugs":[19],"may":[20],"be":[21,95,119],"revealed":[22],"as":[23],"being":[24],"no":[25,129],"better":[26],"than":[27],"existing":[28],"drugs.":[29,71],"However,":[30],"we":[31,106],"show":[32],"standard":[34],"models":[35],"for":[36,66],"vertical":[37],"differentiation":[38],"predicts":[39],"pharmaceutical":[41],"would":[43],"in":[44],"fact":[45],"benefit":[46],"from":[47],"carrying":[48],"voluntary":[50],"trials:":[53],"the":[54,76,87,90,98,104,121,126],"elimination":[55],"of":[56,78,111],"quality":[57],"uncertainty":[58],"increases":[59],"expected":[60],"product":[61],"differentiation,":[62],"thereby":[63],"raising":[64],"prices":[65,93,117],"both":[67],"high-quality":[68],"and":[69,113],"low-quality":[70],"is,":[73],"however,":[74],"disadvantage":[77],"consumers":[79],"trials":[81],"are":[82],"carried":[83],"out.":[84],"By":[85],"extending":[86],"analysis":[88],"case":[91],"when":[92],"cannot":[94,118],"raised,":[96,120],"once":[97],"has":[100,131],"been":[101],"introduced":[102],"on":[103],"market,":[105],"incorporate":[107],"a":[108],"prevalent":[109],"feature":[110],"US":[112],"European":[114],"markets.":[115],"When":[116],"entrant":[122],"firm":[124],"producing":[125],"new":[127],"drug,":[128],"longer":[130],"incentives":[132],"trials.":[138]},"counts_by_year":[{"year":2023,"cited_by_count":1}],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}